Articles published by Silence Therapeutics plc
![](https://mms.businesswire.com/media/20240815016094/en/2216827/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 15, 2024
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20240627515407/en/2171687/5/Silence-Logo-FINAL-rgb.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240620544030/en/2164679/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240530788603/en/2144466/5/Silence-Logo-FINAL-rgb.jpg)
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20240516057102/en/2132956/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress
May 16, 2024
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20240430303611/en/2111334/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240429453581/en/2111976/5/Silence-Logo-FINAL-rgb.jpg)
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20240408451903/en/2091996/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240313711941/en/2064742/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
March 13, 2024
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20240313160113/en/2064736/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240228761492/en/2047118/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024
February 28, 2024
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20240223959968/en/2043035/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240205069427/en/2021560/5/Silence-Logo-FINAL-rgb.jpg)
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20240131830456/en/2012525/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20231201341026/en/1956670/22/Marie_Lindholm.jpg)
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20231114340624/en/1943892/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
November 14, 2023
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20231108841473/en/1936077/5/Silence-Logo-FINAL-rgb.jpg)
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20231101637440/en/1931184/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230926933986/en/1897497/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference
September 26, 2023
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20230906810931/en/1881476/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics to Participate in September Investor Conferences
September 06, 2023
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20230816529739/en/1868267/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics Reports Second Quarter 2023 Results
August 16, 2023
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20230711209680/en/1834453/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230531005007/en/1800166/5/Silence-Logo-FINAL-rgb.jpg)
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20230516005922/en/1795554/5/Silence-Logo-FINAL-rgb.jpg)
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20230504005217/en/1783063/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration
May 04, 2023
Via Business Wire
Tickers
SLN
![](https://mms.businesswire.com/media/20230501005060/en/1777824/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230425005251/en/1772658/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230404005161/en/1754366/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230329005111/en/1749363/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics to Present at Guggenheim’s Genomic Medicines and Rare Disease Days
March 29, 2023
Via Business Wire
Tickers
SLN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.